SARS-COV2 INFECTION
Clinical trials for SARS-COV2 INFECTION explained in plain language.
Never miss a new study
Get alerted when new SARS-COV2 INFECTION trials appear
Sign up with your email to follow new studies for SARS-COV2 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a single infusion of COVID-Fighting antibodies keep High-Risk patients out of the hospital?
Disease control TerminatedThis study tests whether a single infusion of hyperimmune immunoglobulin (hIVIG) — concentrated antibodies from recovered COVID-19 patients — can help adults at high risk (age 55+ or with weakened immune systems) who have early COVID-19. Participants receive either the antibody i…
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
Can a 5-Day pill course prevent long COVID? major trial underway
Prevention OngoingThis study tests whether taking Paxlovid (an antiviral pill) during the first 5 days of a COVID-19 infection can prevent long-COVID symptoms like fatigue, shortness of breath, and memory problems. About 2000 adults aged 18-64 in Norway will receive either Paxlovid or a placebo, p…
Matched conditions: SARS-COV2 INFECTION
Phase: PHASE3 • Sponsor: Haukeland University Hospital • Aim: Prevention
Last updated Jun 23, 2026 11:56 UTC